Terminal Peptide Extensions Augment the Retinal IMPDH1 Catalytic Activity and Attenuate the ATP-induced Fibrillation Events
- PMID: 33733369
- DOI: 10.1007/s12013-021-00973-2
Terminal Peptide Extensions Augment the Retinal IMPDH1 Catalytic Activity and Attenuate the ATP-induced Fibrillation Events
Abstract
Defects in inosine monophosphate dehydrogenase-1 (IMPDH1) lead to insufficient biosyntheses of purine nucleotides. In eyes, these defects are believed to cause retinitis pigmentosa (RP). Major retinal isoforms of IMPDH1 are structurally distinct from those in other tissues, by bearing terminal extensions. Using recombinant mouse IMPDH1 (mH1), we evaluated the kinetics and oligomerization states of the retinal isoforms. Moreover, we adopted molecular simulation tools to study the possible effect of terminal tails on the function of major enzyme isoforms with the aim to find structural evidence in favor of contradictory observations on retinal IMPDH1 function. Our findings indicated higher catalytic activity for the major mouse retinal isoform (mH1603) along with lower fibrillation capacity under the influence of ATP. However, higher mass oligomerization products were formed by the mH1 (603) isoform in the presence of the enzyme inhibitors such as GTP and/or MPA. Collectively, our findings demonstrate that the structural differences between the retinal isoforms have led to functional variations possibly to justify the retinal cells' requirements.
Keywords: Catalytic activity; IMPDH1; Retinal isoform; Retinitis Pigmentosa; Terminal tail.
Similar articles
-
The functional impact of the C/N-terminal extensions of the mouse retinal IMPDH1 isoforms: a kinetic evaluation.Mol Cell Biochem. 2020 Feb;465(1-2):155-164. doi: 10.1007/s11010-019-03675-9. Epub 2019 Dec 14. Mol Cell Biochem. 2020. PMID: 31838626
-
The Impact of Terminal Peptide Extensions of Retinal Inosine 5´Monophosphate Dehydrogenase 1 Isoforms on their DNA-binding Activities.Protein J. 2024 Jun;43(3):592-602. doi: 10.1007/s10930-024-10202-3. Epub 2024 May 11. Protein J. 2024. PMID: 38733555
-
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa.Hum Mol Genet. 2004 Mar 15;13(6):641-50. doi: 10.1093/hmg/ddh061. Hum Mol Genet. 2004. PMID: 14981049
-
IMPDH dysregulation in disease: a mini review.Biochem Soc Trans. 2022 Feb 28;50(1):71-82. doi: 10.1042/BST20210446. Biochem Soc Trans. 2022. PMID: 35191957 Free PMC article. Review.
-
IMP dehydrogenase-linked retinitis pigmentosa.Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):839-49. doi: 10.1080/15257770802146486. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600550 Review.
Cited by
-
Insights on the conformation and appropriate drug-target sites on retinal IMPDH1 using the 604-aa isoform lacking the C-terminal extension.Res Pharm Sci. 2023 Nov 23;18(6):638-647. doi: 10.4103/1735-5362.389951. eCollection 2023 Dec. Res Pharm Sci. 2023. PMID: 39005562 Free PMC article.
-
The gateway to guanine nucleotides: Allosteric regulation of IMP dehydrogenases.Protein Sci. 2022 Sep;31(9):e4399. doi: 10.1002/pro.4399. Protein Sci. 2022. PMID: 36040265 Free PMC article. Review.
-
IMPDH1 retinal variants control filament architecture to tune allosteric regulation.Nat Struct Mol Biol. 2022 Jan;29(1):47-58. doi: 10.1038/s41594-021-00706-2. Epub 2022 Jan 10. Nat Struct Mol Biol. 2022. PMID: 35013599 Free PMC article.
-
Light-sensitive phosphorylation regulates retinal IMPDH1 activity and filament assembly.J Cell Biol. 2024 Apr 1;223(4):e202310139. doi: 10.1083/jcb.202310139. Epub 2024 Feb 7. J Cell Biol. 2024. PMID: 38323936 Free PMC article.
-
Effect on cell survival and cytoophidium assembly of the adRP-10-related IMPDH1 missense mutation Asp226Asn.Front Cell Dev Biol. 2023 Sep 4;11:1234592. doi: 10.3389/fcell.2023.1234592. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37731818 Free PMC article.
References
-
- Bowne, S., Sullivan, S., Blanton, S., Cepko, C. L., Blackshaw, S., Birch, D. G., Hughbanks-Wheaton, D., Heckenlively, J. R. & Daiger, S. P. (2002). Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Human Molecular Genetics, 11(5), 559–568. - DOI
-
- Sohocki, M. M., Daiger, S. P., Bowne, S., Rodriquez, J. A., Northrup, H., Heckenlively, J. R., Birch, D. G., Mintz-Hittner, H., Ruiz, R. S., Lewis, R. A., Saperstein, D. A. & Sullivan, L. S. (2001). Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Human Mutation, 17(1), 42–51. - DOI
-
- Spellicy, C. J., Daiger, S. P., Sullivan, L. S., Zhu, J., Liu, Q., Pierce, E. A. & Bowne, S. J. (2007). Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species. Molecular Vision, 13, 1866–1872. - PubMed
-
- Gunter, J. H., Thomas, E. C., Lengefeld, N., Kruger, S. J., Worton, L., Gardiner, E. M., Jones, A., Barnett, N. L. & Whitehead, J. P. (2008). Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms. The International Journal of Biochemistry & Cell Biology, 40(9), 1716–1728. - DOI
-
- Bateman, A. (1997). The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends in Biochemical Sciences, 22(1), 12–13. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources